A primer on the acute management of intravenous extravasation injuries for the plastic surgeon

Plastic and Reconstructive Surgery - Global Open

Volumn 6, Issue 4, 2018, Pages

  Maly, Connor ^a   Fan, Kenneth L ^b   Rogers, Gary F ^c   Mitchell, Benjamin ^a   Amling, June ^c   Johnson, Kara ^c   Welch, Laura ^c   Oh, Albert K ^c   Chao, Jerry W ^c,d  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^c CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^d GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85053882750     PISSN: None     EISSN: 21697574     Source Type: Journal    
DOI: 10.1097/GOX.0000000000001743     Document Type: Article

References (57)

1. Feldmann H. [History of injections. Pictures from the history of otorhinolaryngology highlighted by exhibits of the German History of Medicine Museum in Ingolstadt]. Laryngorhinootologie. 2000;79:239-246.
2. Coyle C, Griffie J, Czaplewski L. Eliminating extravasation events: A multidisciplinary approach. Infusion Nurses Society. 2015; 38:43-50.
3. Dychter S, Gold D, Carson D, et al. Intravenous therapy: A review of complications and economic considerations of peripheral access. Art Science Infusion Nursing. 2012;35:84-91.
4. Scuderi N, Onesti MG. Antitumor agents: Extravasation, management, and surgical treatment. Ann Plast Surg. 1994;32:39-44.
5. Lake C, Beercroft CL. Extravasation injuries and accidental intra-A rterial injection. Continuing education in anaesthesia. Crit Care Pain. 2012;10:109-112.
6. Doellman D, Bowe-Geddes LA, Franlkin M, et al. Infiltration and extravasation: Update on prevention and management. J Infus Nurs. 2009;32:203-211.
7. Schummer W, Schummer C, Bayer O, et al. Extravasation injury in the perioperative setting. Anesth Analg. 2005;100:722-727, table of contents.
8. Edwards JJ, Samuels D, Fu ES. Forearm compartment syndrome from intravenous mannitol extravasation during general anesthesia. Anesth Analg. 2003;96:245-246, table of contents.
9. St Luke's Cancer Alliance NH. Guidelines for prevention and management of chemotherapy extravasation. 2014;1-18.
10. Guide to extravasation management in adult and pediatric patients. University of Kansas Hospital. 2016. Available at http://icmwk.com/wp-content/uploads/2016/02/Extravasationsmanagement-UoKansasH-.pdf. Accessed July 12, 2016.
11. Kreidieh FY, Moukadem HA, El Saghir NS. Overview, prevention and management of chemotherapy extravasation. World J Clin Oncol. 2016;7:87-97.
12. S. Department of Health and Human Services, National Institute of Health, National Cancer Institute. Common terminology criteria for adverse events (CTAE). 2009.
13. Simona R. A pediatric peripheral intravenous infiltration assessment tool. J Infus Nurs. 2012;35:243-248.
14. Reynolds P, MacLaren R, Mueller S, et al. Management of extravasation injuries: A focused evaluation of noncytotoxic medications. Pharmacotherapy. 2014;34:617-632.
15. Wengström Y, Margulies A; European Oncology Nursing Society Task Force. European Oncology Nursing Society extravasation guidelines. Eur J Oncol Nurs. 2008;12:357-361.
16. ACR manual on contrast media. ACR committee on drugs and contrast media Version 10.2.. 2016. Available at http://www.acr.org/Quality-Safety/Resoruces/Contrast-Manuel. Accessed July 12, 2016.
17. Le A, Patel S. Extravasation of noncytotoxic drugs: A review of the literature. Ann Pharmacother. 2014;48:870-886.
18. Tsai YS, Cheng SM, Ng SP, et al. Squeeze maneuver: An easy way to manage radiological contrast-medium extravasation. Acta Radiol. 2007;48:605-607.
19. Thigpen JL. Peripheral intravenous extravasation: Nursing procedure for initial treatment. Neonatal Netw. 2007;26:379-384.
20. Giunta R. Early subcutaneous wash-out in acute extravasations. Ann Oncol. 2004;15:1146; author reply 1147.
21. Al-Benna S, O'Boyle C, Holley J. Extravasation injuries in adults. ISRN Dermatol. 2013;2013:856541.
22. Loubani OM, Green RS. A systematic review of extravasation and local tissue injury from administration of vasopressors through peripheral intravenous catheters and central venous catheters. J Crit Care. 2015;30:653.e9-653.17.
23. Sinclair M, Bailey M, McAree B, et al. Rapid epinephrine 'reversal' with phentolamine following autoinjector inoculation. Myels. Vascular Med. 2011;16:215-216.
24. Mathez C, Favrat B, Staeger P. Management options for accidental injection of epinephrine from an autoinjector: A case report. J Med Case Rep. 2009;3:7268.
25. Cardenas-Garcia J, Schaub KF, Belchikov YG, et al. Safety of peripheral intravenous administration of vasoactive medication. J Hosp Med. 2015;10:581-585.
26. Gault DT. Extravasation injuries. Br J Plast Surg. 1993;46:91-96.
27. Dugan S, Le J, Jew RK. Maximum tolerated osmolarity for peripheral administration of parenteral nutrition in pediatric patients. JPEN J Parenter Enteral Nutr. 2014;38:847-851.
28. Wall CJ, Lynch J, Harris IA, et al.; Liverpool(Sydney) and Royal Melbourne Hospitals. Clinical practice guidelines for the management of acute limb compartment syndrome following trauma. ANZ J Surg. 2010;80:151-156.
29. Schaverien MV, Evison D, McCulley SJ. Management of large volume CT contrast medium extravasation injury: Technical refinement and literature review. J Plast Reconstr Aesthet Surg. 2008;61:562-565; discussion 565.
30. Schulmeister L. Vesicant chemotherapy extravasation antidotes and treatments. Clin J Oncol Nurs. 2009;13:395-398.
31. Gil ME, Mateu J. Treatment of extravasation from parenteral nutrition solution. Ann Pharmacother. 1998;32:51-55.
32. Nicola R, Shaqdan KW, Aran S, et al. Contrast media extravasation of computed tomography and magnetic resonance imaging: Management guidelines for the radiologist. Curr Probl Diagn Radiol. 2016;45:161-164.
33. Rose TA Jr, Choi JW. Intravenous imaging contrast media complications: The basics that every clinician needs to know. Am J Med. 2015;128:943-949.
34. Bellin MF, Jakobsen JA, Tomassin I, et al.; Contrast Media Safety Committee Of The European Society Of Urogenital Radiology. Contrast medium extravasation injury: Guidelines for prevention and management. Eur Radiol. 2002;12:2807-2812.
35. Zhu QC, Luo RC, Miao JX, et al. Topical dimethyl sulfoxide and intralesional hyaluronidase administration for vinorelbine extravasation-induced rat skin injury. J South Med Univ. 2007;27:9.
36. Bertelli G, Dini D, Forno GB, et al. Hyaluronidase as an antidote to extravasation of Vinca alkaloids: Clinical results. J Cancer Res Clin Oncol. 1994;120:505-506.
37. APP Pharmaceuticals, LLC. Available at http://medlibrary.org/lib/rx/meds/vinblastine-sulfate-1/page/4/. Accessed July 2016.
38. Gonzalez T. Chemotherapy extravasations: Prevention, identification, management, and documentation. Clin J Oncol Nurs. 2013;17:61-66.
39. Beaulieu MJ. Hyaluronidase for extravasation management. Neonatal Netw. 2012;31:413-418.
40. Conde-Estévez D, Mateu-de Antonio J. Treatment of anthracycline extravasations using dexrazoxane. Clin Transl Oncol. 2014;16:11-17.
41. Mouridsen HT, Langer SW, Buter J, et al. Treatment of anthracycline extravasation with Savene (dexrazoxane): Results from two prospective clinical multicentre studies. Ann Oncol. 2007;18:546-550.
42. Langer SW. Dexrazoxane for the treatment of chemotherapyrelated side effects. Cancer Manag Res. 2014;6:357-363.
43. European Medicines Agency. 2006. Available at http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000682/human-med-001047. jsp&mid=WC0b01ac058001d124. Accessed July 2016.
44. Jordan K, Behlendorf T, Mueller F, et al. Anthracycline extravasation injuries: Management with dexrazoxane. Ther Clin Risk Manag. 2009;5:361-366.
45. Cassagnol M. Management of chemotherapy extravasations. US Pharm. 2009;34:3-11.
46. Fontaine C, Noens L, Pierre P, et al. Savene® (dexrazoxane) use in clinical practice. Support Care Cancer. 2012;20:1109-1112.
47. Langer SW, Sehested M, Jensen PB. Anthracycline extravasation: A comprehensive review of experimental and clinical treatments. Tumori. 2009;95:273-282.
48. Olver IN, Aisner J, Hament A, et al. A prospective study of topical dimethyl sulfoxide for treating anthracycline extravasation. J Clin Oncol. 1988;6:1732-1735.
49. Schulmeister L. Extravasation management. Semin Oncol Nurs. 2007;23:184-190.
50. Ener RA, Meglathery SB, Styler M. Extravasation of systemic hemato-oncological therapies. Ann Oncol. 2004;15:858-862.
51. Boulanger J, Ducharme A, Dufour A, et al.; Comité de l'évolution de la pratique des soins pharmaceutiques (CEPSP); Comité de l'évolution des pratiques en oncologie (CEPO). Management of the extravasation of anti-neoplastic agents. Support Care Cancer. 2015;23:1459-1471.
52. Okan D, Woo K, Ayello EA, et al. The role of moisture balance in wound healing. Adv Skin Wound Care. 2007;20:39-53; quiz 53.
53. Sawatzky-Dickson D, Bodnaryk K. Neonatal intravenous extravasation injuries: Evaluation of a wound care protocol. Neonatal Netw. 2006;25:13-19.
54. Attinger CE, Janis JE, Steinberg, J, et al. Clinical approach to wounds: Debridement and wound bed preparation including the use of dressings and wound-healing adjuvants. Plast Reconstr Surg. 2006;117: 72S-109S.
55. Sung KY, Lee SY. Nonoperative management of extravasation injuries associated with neonatal parenteral nutrition using multiple punctures and a hydrocolloid dressing. Wounds. 2016;28:145-151.
56. Schrijvers DL. Extravasation: A dreaded complication of chemotherapy. Ann Oncol. 2003;3:26-30.
57. Shenaq SM, Abbase EH, Friedman JD. Soft-tissue reconstruction following extravasation of chemotherapeutic agents. Surg Oncol Clin N Am. 1996;5:825-845.